Canada markets closed

Vistagen Therapeutics, Inc. (VTGN)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.7400-0.0900 (-1.86%)
At close: 04:00PM EDT
4.7000 -0.04 (-0.84%)
After hours: 06:10PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 130.26M
Enterprise Value 5.96M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)62.50
Price/Book (mrq)1.06
Enterprise Value/Revenue 5.72
Enterprise Value/EBITDA -0.18

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 315.00%
S&P500 52-Week Change 323.10%
52 Week High 324.7100
52 Week Low 31.6200
50-Day Moving Average 34.7314
200-Day Moving Average 34.5208

Share Statistics

Avg Vol (3 month) 3264.39k
Avg Vol (10 day) 3198.34k
Shares Outstanding 527.03M
Implied Shares Outstanding 627.03M
Float 815.25M
% Held by Insiders 10.20%
% Held by Institutions 163.13%
Shares Short (Apr 15, 2024) 41.29M
Short Ratio (Apr 15, 2024) 44.09
Short % of Float (Apr 15, 2024) 47.28%
Short % of Shares Outstanding (Apr 15, 2024) 44.78%
Shares Short (prior month Mar 15, 2024) 41.33M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:30
Last Split Date 3Jun 07, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,916.38%

Management Effectiveness

Return on Assets (ttm)-26.36%
Return on Equity (ttm)-44.55%

Income Statement

Revenue (ttm)1.04M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)129.10%
Gross Profit (ttm)N/A
EBITDA -33.77M
Net Income Avi to Common (ttm)-32.07M
Diluted EPS (ttm)-2.9600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)126.56M
Total Cash Per Share (mrq)4.68
Total Debt (mrq)2.25M
Total Debt/Equity (mrq)1.83%
Current Ratio (mrq)30.76
Book Value Per Share (mrq)4.56

Cash Flow Statement

Operating Cash Flow (ttm)-26.09M
Levered Free Cash Flow (ttm)-18.72M